• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET UK LTD. BIOLOX DELTA CER FEM HD 32/+6MM T1; HIP PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET UK LTD. BIOLOX DELTA CER FEM HD 32/+6MM T1; HIP PROSTHESIS Back to Search Results
Catalog Number 650-1160
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 02/08/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).D10: item name: tprlc 133 t1 pps ho 16x152mm; item number: 51-104160; lot: 7723717.G2¿foreign¿netherlands.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Event or Problem Description
It was reported that the patient underwent revision surgery due to a femoral head fracture after the patient stood up, approximately 2 days post-implantation.Due diligence is in progress for this complaint; to date no additional information or product has been received.
 
Additional Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional and/or corrected information.The following sections were updated: b4, b5, g1-2, g3, g6, h2, h3, h6, h11.No product was returned or pictures provided; a product evaluation could not be performed.A review of the device manufacturing records confirmed no abnormalities or deviations.Review of the complaint history identified additional similar complaints for the reported item and no additional similar complaints for the reported part and lot combination.Radiographs were provided two views of the left hip (one showing the fractured head and one immediate postoperative) and reviewed by a radiologist.The review confirmed a left total hip arthroplasty with a fracture of the femoral head.Postoperative images show the implant to be appropriately sized, with no contributing factors identified.A definitive root cause could not be determined.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
No further event information available at the time of this report. .
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOLOX DELTA CER FEM HD 32/+6MM T1
Common Device Name
HIP PROSTHESIS
Manufacturer (Section D)
BIOMET UK LTD.
waterton industrial estates
bridgend
Manufacturer (Section G)
BIOMET UK LTD.
waterton industrial estates
bridgend CF31 3XA
UK   CF31 3XA
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key21558271
Report Number3002806535-2025-00114
Device Sequence Number9262096
Product Code LZO
UDI-Device Identifier00887868271540
UDI-Public(01)00887868271540(17)330118(10)3140863
Combination Product (Y/N)N
Initial Reporter CountryNL
PMA/510(K) Number
K192683
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Catalogue Number650-1160
Device Lot Number3140863
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/10/2025
Supplement Date Received by Manufacturer08/13/2025
Initial Report FDA Received Date03/10/2025
Supplement Report FDA Received Date08/13/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/18/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10 NARRATIVE.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexUnknown
-
-